Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-12 |
mRNA | ELAVL4 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-06 |
mRNA | SLAMF7 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-10 |
mRNA | FGR | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-08 |
mRNA | CLDN3 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-07 |
mRNA | ILDR1 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-09 |
mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-12 |
mRNA | GADD45G | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-09 |
mRNA | ATG4A | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-08 |
mRNA | PLBD2 | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-12 |